A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids
- Status
- COMPLETED
- Phase
- PHASE3
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- Status
- RECRUITING
- Phase
- PHASE3
Pembro Plus CAR T-cell Therapy in R/R in PMBCL
- Status
- RECRUITING
- Phase
- PHASE2
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires
- Status
- UNKNOWN
- Phase
- N/A
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Insomnia Treatment and EMA (Ecological Momentary Assessment) Outcomes
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3